Home > PS Ratio > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of KWALITY PHARMACEUTICALS is 2.21.

Share Price ₹897.6Nov 25,2025
Market Cap ₹933.5 Cr
Sales-TTM₹422.6 CrTTM-Consolidated Results
Price/Sales2.21xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of KWALITY PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of KWALITY PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹933.5 Cr] as on Nov 25,2025

(/) Sales [ ₹422.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.21x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay '2.21 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of KWALITY PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of KWALITY PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of KWALITY PHARMACEUTICALS


PS Ratio Performance Analysis for KWALITY PHARMACEUTICALS

- KWALITY PHARMACEUTICALS 's latest p/e ratio is 2.21x.

- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.33x.

- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 1.32x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.44x.

- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 0.22x.


How does KWALITY PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
KWALITY PHARMACEUTICALS 422.62.21933.5
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.73425,102.0
DIVIS LABORATORIES LTD10,029.016.98170,299.0
CIPLA LTD28,349.64.29121,735.0
TORRENT PHARMACEUTICALS LTD12,248.010.35126,753.0
DR REDDYS LABORATORIES LTD34,310.03.01103,155.0
MANKIND PHARMA LTD13,576.96.8292,592.0
ZYDUS LIFESCIENCES LTD24,493.93.8193,328.2
LUPIN LTD24,750.73.7793,364.5
AUROBINDO PHARMA LTD32,514.52.1670,131.8
ABBOTT INDIA LTD6,714.49.5864,331.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KWALITY PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.16x
Max industry PS 16.98x
Median industry PS 4.29x
Average industry PS 6.43x



You may also like the below Video Courses